Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Nonsteroidal Anti-Androgens × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Cisplatin 859 Cyclophosphamide 808 Carboplatin 802 Radiotherapy 748 Bevacizumab 703 Gemcitabine 677 Docetaxel 634 pembrolizumab 632 Paclitaxel 620 Oxaliplatin 584 Capecitabine 546 Fluorouracil 486 Rituximab 477 Nivolumab 421 Dexamethasone 415 Etoposide 392 Doxorubicin 382 Irinotecan 375 Drug Therapy 326 Leucovorin 322 Cytarabine 296 Cetuximab 283 Lenalidomide 277 Trastuzumab 275 Pemetrexed 270 durvalumab 242 Filgrastim 242 Prednisone 229 Temozolomide 227 Magnetic Resonance Spectroscopy 224

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05327647 2025-12-18

BicaBCa

CHU de Quebec-Universite Laval

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡